Japan Vietnam Medical Instrument JSC Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Dec'25

Dec'24

Dec'23

Dec'22

Mar'21

Mar'20

Mar'19

Net Sales

7,63,153.28

6,11,540.46

5,76,287.16

4,85,210.26

4,11,416.95

5,17,172.86

6,15,074.05

Other Operating Income

0.00

Total Operating income

7,63,153.28

6,11,540.46

5,76,287.16

4,85,210.26

4,11,416.95

5,17,172.86

6,15,074.05

Raw Material Cost

6,18,149.53

4,71,290.16

4,46,810.68

4,03,332.90

3,75,562.99

4,08,115.25

5,06,533.49

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

61,016.22

57,130.65

60,492.38

56,003.81

0.00

51,271.33

0.00

Power Cost

0.00

Manufacturing Expenses

14,682.16

5,437.22

5,291.62

3,379.50

3,674.47

9.04

1,140.07

Selling and Distribution Expenses

92,320.01

1,03,740.68

1,02,628.93

99,274.73

1,10,225.00

1,20,873.29

1,07,540.91

Other Expenses

-7,569.84

-6,256.79

-6,578.40

-5,938.33

-367.45

-5,128.04

-114.01

Total Expenditure (Excl Depreciation)

7,10,469.53

5,75,030.84

5,49,439.61

5,02,607.63

4,85,787.98

5,28,988.54

6,14,074.40

Operating Profit (PBDIT) excl Other Income

52683.7

36509.6

26847.5

-17397.4

-74371

-11815.699999999999

999.5999999999999

Other Income

23,452.46

27,792.61

34,368.35

16,531.74

1,493.17

14,556.23

12,710.75

Operating Profit (PBDIT)

1,00,986.92

99,908.03

1,08,670.00

39,243.64

37,209.91

80,050.40

84,643.53

Interest

14,682.16

5,437.22

5,291.62

3,379.50

3,674.47

9.04

1,140.07

Exceptional Items

0.00

Gross Profit (PBDT)

1,45,003.75

1,40,250.30

1,29,476.48

81,877.36

35,853.97

1,09,057.61

1,08,540.55

Depreciation

24,850.72

35,605.80

47,454.10

40,109.27

1,10,087.77

77,309.85

71,376.91

Profit Before Tax

61,454.04

58,865.01

55,924.27

-4,245.13

-76,552.33

2,731.51

12,126.54

Tax

11,504.03

18,528.91

3,284.43

971.46

106.85

-64.52

680.88

Provisions and contingencies

0.00

Profit After Tax

49,945.28

40,282.23

52,634.38

-5,161.08

-76,659.19

2,796.03

11,445.66

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

49,945.28

40,282.23

52,634.38

-5,161.08

-76,659.19

2,796.03

11,445.66

Share in Profit of Associates

0.00

Minority Interest

4.73

53.87

5.46

-55.50

0.00

Other related items

0.00

Consolidated Net Profit

49,950.01

40,336.10

52,639.84

-5,216.58

-76,659.19

2,796.03

11,445.66

Equity Capital

0.00

Face Value

10000.0

Reserves

5,89,376.75

5,39,431.47

4,99,149.24

4,46,514.85

4,54,718.99

5,31,378.17

5,28,582.14

Earnings per share (EPS)

443.96

358.06

467.86

-45.88

-681.0

24.85

101.74

Diluted Earnings per share

443.96

358.06

467.86

-45.88

-681.0

24.85

101.74

Operating Profit Margin (Excl OI)

6.9%

5.97%

4.66%

-3.59%

-18.08%

-2.28%

0.09%

Gross Profit Margin

11.31%

15.45%

17.94%

7.39%

8.15%

15.48%

13.58%

PAT Margin

6.54%

6.59%

9.13%

-1.06%

-18.63%

0.54%

1.86%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Dec 2025 is 24.79% vs 6.12% in Dec 2024

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 23.83% vs -23.37% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 7.51% vs -2.94% in Dec 2024

Interest

YoY Growth in year ended Dec 2025 is 170.03% vs 2.75% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Japan Vietnam Medical Instrument JSC With

Select Peers

Figures in Million

Consolidate Annual Results

Change(VND)

Change(%)

Net Sales

7,63,153.28

Other Operating Income

0.00

Total Operating income

7,63,153.28

Raw Material Cost

6,18,149.53

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

61,016.22

Power Cost

0.00

Manufacturing Expenses

14,682.16

Selling and Distribution Expenses

92,320.01

Other Expenses

-7,569.84

0.00

-7,569.84

Total Expenditure (Excl Depreciation)

7,10,469.53

Operating Profit (PBDIT) excl Other Income

52,683.74

0.00

52,683.74

Other Income

23,452.46

Operating Profit (PBDIT)

1,00,986.92

Interest

14,682.16

Exceptional Items

0.00

Gross Profit (PBDT)

1,45,003.75

Depreciation

24,850.72

Profit Before Tax

61,454.04

Tax

11,504.03

Provisions and contingencies

0.00

Profit After Tax

49,945.28

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

49,945.28

Share in Profit of Associates

0.00

Minority Interest

4.73

Other related items

0.00

Consolidated Net Profit

49,950.01

Equity Capital

0.00

Face Value

10,000.00

0.00

Reserves

5,89,376.75

Earnings per share (EPS)

443.96

Diluted Earnings per share

443.96

Operating Profit Margin (Excl OI)

6.90%

0.00

6.90%

Gross Profit Margin

11.31%

0.00

11.31%

PAT Margin

6.54%

0.00

6.54%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 76,315.33 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 24.79% vs 6.12% in Dec 2024

Annual - Consolidate Net Profit

Consolidate Net Profit 4,995.00 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 23.83% vs -23.37% in Dec 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 7,753.45 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 7.51% vs -2.94% in Dec 2024

Annual - Interest

Interest 1,468.22 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 170.03% vs 2.75% in Dec 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 6.90%

in Dec 2025

Figures in %

YoY Growth in year ended Dec 2025 has improved from Dec 2024